Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil S Millar

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
European Journal of Pharmacology|May 1, 2007
Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptorsPaola V Plazas, Jessica Savino, Sebastian Kracun, et al.
European Journal of Pharmacology|February 7, 2016
Inhibition of human α7 nicotinic acetylcholine receptors by cyclic monoterpene carveolYosra Lozon, Ahmed Sultan, Stuart J Lansdell, et al.
Molecular Pharmacology|June 16, 2005
Effects of quinine, quinidine, and chloroquine on alpha9alpha10 nicotinic cholinergic receptorsJimena A Ballestero, Paola V Plazas, Sebastian Kracun, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 31, 2012
A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in ratsReza J Rasoulpour, Robert G Ellis-Hutchings, Claire Terry, et al.
Molecular Pharmacology|January 11, 2017
Differential Contribution of Subunit Interfaces to α9α10 Nicotinic Acetylcholine Receptor FunctionJuan Carlos Boffi, Irina Marcovich, JasKiran K Gill-Thind, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 3, 2009
The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalinClaudia S Bauer, Manuela Nieto-Rostro, Wahida Rahman, et al.
European Journal of Pharmacology|October 7, 2004
Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screeningPeter J Craig, Suchira Bose, Ruud Zwart, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
European Journal of Pharmacology|May 1, 2007
Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptorsPaola V Plazas, Jessica Savino, Sebastian Kracun, et al.
European Journal of Pharmacology|February 7, 2016
Inhibition of human α7 nicotinic acetylcholine receptors by cyclic monoterpene carveolYosra Lozon, Ahmed Sultan, Stuart J Lansdell, et al.
Molecular Pharmacology|June 16, 2005
Effects of quinine, quinidine, and chloroquine on alpha9alpha10 nicotinic cholinergic receptorsJimena A Ballestero, Paola V Plazas, Sebastian Kracun, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 31, 2012
A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in ratsReza J Rasoulpour, Robert G Ellis-Hutchings, Claire Terry, et al.
Molecular Pharmacology|January 11, 2017
Differential Contribution of Subunit Interfaces to α9α10 Nicotinic Acetylcholine Receptor FunctionJuan Carlos Boffi, Irina Marcovich, JasKiran K Gill-Thind, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 3, 2009
The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalinClaudia S Bauer, Manuela Nieto-Rostro, Wahida Rahman, et al.
European Journal of Pharmacology|October 7, 2004
Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screeningPeter J Craig, Suchira Bose, Ruud Zwart, et al.
Pageof 6